Mammary Neoplasms
group
Neoplasms; Skin and Connective Tissue Diseases
Neoplastic Process
2780
385
0.400
None
1.000
94
1993
2019
Carcinoma breast stage IV
disease
Neoplastic Process
573
14
0.100
None
1.000
53
2003
2020
Obesity
disease
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
Disease or Syndrome
2821
1111
0.200
None
0.943
35
2003
2019
Advanced breast cancer
disease
Neoplastic Process
151
3
0.100
None
1.000
25
2002
2020
Neoplasm Metastasis
phenotype
Pathological Conditions, Signs and Symptoms; Neoplasms
Neoplastic Process
6385
327
0.400
None
1.000
22
1999
2019
Carcinogenesis
phenotype
Pathological Conditions, Signs and Symptoms; Neoplasms
Neoplastic Process
6243
355
0.100
None
1.000
17
1999
2019
×
CUI:
C0030193
Disease:
Pain
Pain
phenotype
Pathological Conditions, Signs and Symptoms
Sign or Symptom
1554
196
0.100
None
1.000
17
2010
2020
Endometrioma
disease
Female Urogenital Diseases and Pregnancy Complications
Neoplastic Process
279
4
0.400
None
0.933
15
2002
2019
Aortic Valve Insufficiency
disease
Cardiovascular Diseases
Disease or Syndrome
377
8
0.100
None
0.923
13
2015
2020
Choriocarcinoma
disease
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
Neoplastic Process
431
2
0.100
None
1.000
13
1992
2019
Non-Small Cell Lung Carcinoma
disease
Neoplasms; Respiratory Tract Diseases
Neoplastic Process
3926
712
0.100
None
1.000
13
2009
2016
AROMATASE EXCESS SYNDROME
disease
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Male Urogenital Diseases; Endocrine System Diseases
Disease or Syndrome
14
0.800
limited
1.000
12
1998
2019
Uterine Fibroids
group
Neoplasms
Neoplastic Process
569
154
0.100
None
0.917
12
1994
2016
Adrenocortical carcinoma
disease
Neoplasms; Endocrine System Diseases
Neoplastic Process
281
46
0.100
None
0.917
12
2000
2019
Endometrial Neoplasms
group
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
Neoplastic Process
261
32
0.100
None
1.000
11
1994
2009
Fibroid Tumor
disease
Neoplasms
Neoplastic Process
413
14
0.100
None
0.909
11
1994
2016
Carcinoma, Ovarian Epithelial
disease
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
Neoplastic Process
2841
327
0.100
None
0.900
10
1994
2019
Sjogren's Syndrome
disease
Eye Diseases; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases; Stomatognathic Diseases
Disease or Syndrome
481
47
0.220
None
1.000
9
1998
2015
Sicca Syndrome
disease
Eye Diseases; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases; Stomatognathic Diseases
Disease or Syndrome
132
4
0.200
None
1.000
8
1998
2015
Bone Cysts, Aneurysmal
disease
Neoplasms; Musculoskeletal Diseases
Disease or Syndrome
79
5
0.080
None
1.000
8
2016
2019
Noninfiltrating Intraductal Carcinoma
disease
Neoplasms
Neoplastic Process
486
13
0.080
None
1.000
8
2008
2017
Thyroid carcinoma
disease
Neoplasms; Endocrine System Diseases
Neoplastic Process
1175
145
0.070
None
1.000
7
2002
2009
Secondary Neoplasm
group
Pathological Conditions, Signs and Symptoms; Neoplasms
Neoplastic Process
2492
85
0.070
None
1.000
7
1999
2019
Tumor Progression
phenotype
Pathological Conditions, Signs and Symptoms
Neoplastic Process
3865
72
0.070
None
1.000
7
2003
2018
Early-Stage Breast Carcinoma
disease
Neoplasms; Skin and Connective Tissue Diseases
Neoplastic Process
142
7
0.070
None
1.000
7
2017
2020